To investigate the influence of BH3 mimetics on the persistence of CD19.CAR-T cells, the expression of inhibitory molecules PD-1 and LAG-3 on both CD4+ and CD8+ CAR-T cells were monitored during the repetitive tumor challenge in pre-,simultaneous and post-treatment systems. The gene discussed is LAG3; the disease is neoplasm.